Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico. This investment will integrate advanced technologies and expand production capacity within the existing campus to support the company’s growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology. The enhanced facility will be among those that will manufacture orforglipron, Lill...